Full history for every metric is available with a Kvantra account

Stock profile

Erika B-Cure Laser Ltd (BCUR.TA)

Country: IsraelSector: HealthcareIndustry: Medical - DevicesExchange: TLV

Delisted · last close 10 Nov 2025

Current price
21.60 ILA+2.86%
Last close 10 Nov 2025
Benchmarks

Key financial summary

Financials in ILS
201920202021202220232024TTM
Total revenueILS m518697503038-19
Operating profitILS m-10-
Net profitILS m212-22-33-19-9-
EPS reportedILS-0.09-
Operating cashflow per shareILS-0.04-0.04
Capex per shareILS0.000.00
FCF per shareILS-0.04-0.04
Free cash flowILS m-42
Net debtILS m-4-5
Book value equityILS m1513
Book value per shareILS0.140.13
Number of sharesm104.17105
DPS (TTM paid)ILS0.000.00

Financial summary

Financials in ILS
201920202021202220232024TTM
Value
P/E TTMx--
P/B LTMx1.611.31
P/S LTMx0.64-0.95
P/FCF LTMx-5.6211.00
EV/EBITDA LTMx-3.08-9.19
EV/Sales LTMx0.67-0.67
Earnings Yield LTM%-39.02%-54.11%
FCF Yield%-17.80%9.09%
Quality
ROE%-62.98%-48.86%
ROIC%-46.49%-46.49%
Operating margin%-26.15%-26.15%
Gross margin%68.62%68.62%
FCF/Sales%-11.38%-11.38%
Growth and momentum
EPS Growth YoY%--
Sales Growth YoY%+27.03%-
Net Income Growth YoY%--
FCF Growth%--
Operating Profit Growth%--
Dividend and capital structure
Dividend Yield%0.00%0.00%
Dividend Growth%0.00%0.00%
Payout Ratio%0.00%0.00%
FCF/Debtx-1.400.64
Net Debt/EBITDAx-0.16-0.16
EBIT/Net interestx-10.92-10.92
Net debt/market cap%-16.53%-28.87%
Net debt/Equityx-0.27-0.38
Gross debt/equityx0.210.18

Company overview

Erika B-Cure Laser Ltd, established in Haifa, Israel in 2007, is a company dedicated to the full lifecycle of its B-Cure laser product line, from development and manufacturing to global marketing, sales, and distribution. Formerly known as Erica Carmel Ltd until its rebranding in January 2022, the company offers a diverse array of laser devices tailored for various therapeutic applications in both domestic and international markets. Their product portfolio includes: The B-Cure Laser Classic, a medical device for home use that addresses a broad spectrum of conditions including general pain, orthopedic issues, dermatological problems, inflammation, and supports wound healing. The B-Cure Laser Pro, designed to treat more severe or chronic ailments such as persistent orthopedic challenges, diabetic wounds, and difficulties in recovery, including mucositis. The B-Cure Laser Sport, a home-based device for managing sports injuries, athletic discomfort, and other orthopedic concerns. The professional-grade B-Cure Laser Sport Pro, which provides advanced treatment for sports-related injuries, pain relief in muscles and various body areas, and helps combat infections like Achilles tendonitis. For dental professionals, the B-Cure Laser Dental is an in-clinic device formulated to tackle a variety of oral health problems, alleviate gum pain and inflammation, expedite recovery post-dental procedures (including implants), and reduce associated swelling and discomfort. Additionally, the B-Pro Dental Laser Cure is available for dental clinics, specifically engineered to address diverse dental issues and infections.

WebsiteN/A
IndustryMedical - Devices
CountryIsrael
Trades inILA

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Delisted · last close 10 Nov 2025

Erika B-Cure Laser Ltd (BCUR.TA)

BCUR.TA · TLV · Healthcare
21.60 ILA+2.86%
Benchmarks
Financialsin ILS
20232024TTM
About

Erika B-Cure Laser Ltd, established in Haifa, Israel in 2007, is a company dedicated to the full lifecycle of its B-Cure laser product line, from development and manufacturing to global marketing, sales, and distribution. Formerly known as Erica Carmel Ltd until its rebranding in January 2022, the company offers a diverse array of laser devices tailored for various therapeutic applications in both domestic and international markets. Their product portfolio includes: The B-Cure Laser Classic, a medical device for home use that addresses a broad spectrum of conditions including general pain, orthopedic issues, dermatological problems, inflammation, and supports wound healing. The B-Cure Laser Pro, designed to treat more severe or chronic ailments such as persistent orthopedic challenges, diabetic wounds, and difficulties in recovery, including mucositis. The B-Cure Laser Sport, a home-based device for managing sports injuries, athletic discomfort, and other orthopedic concerns. The professional-grade B-Cure Laser Sport Pro, which provides advanced treatment for sports-related injuries, pain relief in muscles and various body areas, and helps combat infections like Achilles tendonitis. For dental professionals, the B-Cure Laser Dental is an in-clinic device formulated to tackle a variety of oral health problems, alleviate gum pain and inflammation, expedite recovery post-dental procedures (including implants), and reduce associated swelling and discomfort. Additionally, the B-Pro Dental Laser Cure is available for dental clinics, specifically engineered to address diverse dental issues and infections.

IndustryMedical - Devices
CountryIsrael
Trades inILA

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free